Association of Mycoplasma hominis infection with prostate cancer

Oncotarget

Volumn 2, Issue 4, 2011, Pages 289-297

  Barykova, Yulia A ^a   Logunov, Denis Yu ^a   Shmarov, Maxim M ^a   Vinarov, Andrei Z ^b   Fiev, Dmitry N ^b   Vinarova, Natalia A ^b   Rakovskaya, Irina V ^a   Baker, Patricia Stanhope ^c   Shyshynova, Inna ^c,e   Stephenson, Andrew J ^d   Klein, Eric A ^d   Naroditsky, Boris S ^a   Gintsburg, Alexander L ^a   Gudkov, Andrei V ^c,e  

^a GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^c CLEVELAND BIOLABS INC   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Benign prostate hyperplasia; Diagnostics; PCR; Prostate biopsies; Prostate intraepithelial neoplasia

Indexed keywords

CANCER ANTIBODY; GENOMIC DNA; IMMUNOGLOBULIN G ANTIBODY; PROSTATE SPECIFIC ANTIGEN; ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; APOPTOSIS; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD LEVEL; CANCER GRADING; CANCER RESISTANCE; CANCER SCREENING; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR DYNAMICS; MYCOPLASMA HOMINIS; MYCOPLASMA HOMINIS INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE CHARACTERIZATION; BIOPSY; BLOOD; CARCINOMA; COHORT ANALYSIS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MYCOPLASMOSIS; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; RUSSIAN FEDERATION;

AGED; AGED, 80 AND OVER; ANTIBODIES; BIOPSY; CARCINOMA; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RUSSIA;

EID: 80052973510     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.256     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun M.s Cancer Statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
2. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nagai Y, Isaacs WB, Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007; 7: 256-69.
3. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006; 124: 823-35.
4. Sutcliffe S, Platz EA. Inflammation and prostate cancer: a focus on infections. Curr Urol Rep. 2008; 9: 243-9.
5. Wagenlehner FM, Elkahwaji JE, Algaba F, Bjerklund-Johansen T, Naber KG, Hartung R, Weidner W. The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int. 2007; 100:733-7.
6. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006; 2: e25.
7. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998; 62:1094-156.
8. Sun G, Xu X, Wang Y, Shen X, Chen Z, Yang J. Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells. Infect Immun. 2008; 76: 4405-13.
9. Feng SH, Tsai S, Rodriguez J, Lo SC. Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol. 1999; 19: 7995-8002.
10. Gong M, Meng L, Jiang B, Zhang J, Yang H, Wu J, Shou C. p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR. Mol Cancer Ther. 2008; 7: 530-7.
11. Jiang S, Zhang S, Langenfeld J, Lo SC, Rogers MB. Mycoplasma infection transforms normal lung cells and induces bone morphogenetic protein 2 expression by posttranscriptional mechanisms. J Cell Biochem. 2008; 104: 580-94.
12. Namiki K, Goodison S, Porvasnik S, Allan RW, Iczkowski KA, Urbanek C, Reyes L, Sakamoto N, Rosser CJ. Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One. 2009; 4: e6872.
13. Pehlivan M, Pehlivan S, Onay H, Koyuncuoglu M, Kirkali Z. Can mycoplasma-mediated oncogenesis be responsible for formation of conventional renal cell carcinoma? Urology. 2005; 65: 411-4.
14. Tsai S, Wear DJ, Shih JW, Lo SC. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci USA. 1995; 92: 10197-201.
15. Zhang B, Shih JW, Wear DJ, Tsai S, Lo SC. High-level expression of H-ras and c-myc oncogenes in mycoplasmamediated malignant cell transformation. Proc Soc Exp Biol Med. 1997; 214: 359-66.
16. Logunov DY, Scheblyakov DV, Zubkova OV, Shmarov MM, Rakovskaya IV, Gurova KV, Tararova ND, Burdelya LG, Naroditsky BS, Ginzburg AL, Gudkov AV. Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene. 2008; 27: 4521-31.
17. Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle. 2007; 6:1006-10.
18. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005; 5: 749-59.
19. Prosorovsky S, Rakovskaya IV, Vulfovich YV. Medical micoplasmology. - M.: Medcine, 1995,-288.
20. Kovalev YN, Ilin II, et al. To clinical peculiarity and pathogenesis of chronic prostatitis. "Bulletin of dermatology and venereology", 1995.
21. Molochnikov V.A., Ilin I.I. Chronic urethrogenic prostatitis. - Medcine, 2004, p.288.
22. Shih WJ, Collins J, Mitchell B, Wierzbinski B. Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia. J Natl Med Assoc. 1994; 86: 667-70.